Do cardiometabolic drugs reduce epicardial adipose tissue?
Cardiometabolic drugs, particularly GLP-1 receptor agonists, significantly reduce epicardial adipose tissue, which may be especially beneficial for younger patients with high BMI.
Cardiometabolic drugs show a significant beneficial effect on EAT reduction. GLP-1 RA was more effective than SGLT2-i, while statins had a rather mild effect. We believe that the most effective treatment with these drugs should target younger patients with high BMI.
Myasoedova et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: